Literature DB >> 19523267

Exercise capacity reflects ventricular function in patients having the Fontan circulation.

Katrin Klimes1, Stanislav Ovroutski, Hashim Abdul-Khaliq, Peter Ewert, Vladimir Alexi-Meskishvili, Titus Kuehne, Matthias Gutberlet, Felix Berger.   

Abstract

BACKGROUND: In this study we sought to determine, first, whether maximal exercise capacity reflects ventricular function, and second, whether the age of the patient, and the age of completion of the Fontan circulation, influence ventricular function and exercise performance. METHODS AND
RESULTS: Cardiac magnetic resonance imaging and cardiopulmonary exercise testing were performed in 29 patients at a median time of 6.9 years after completion of the Fontan circulation. We divided the patients into 2 groups, the first 19 having their operation below the age of 18 years, and the second group, of 10 patients, having completion of the Fontan circulation when they were older than 18 years. Parameters for ventricular function and exercise were compared for both groups with controls. Compared to controls, the younger patients had normal end-diastolic ventricular volumes, but significantly impaired ventricular function, lower maximal work load and consumption of oxygen. The older patients had greater end-diastolic ventricular volumes, and significantly poorer ventricular function than both the younger patients and the controls. Maximal work load and consumption of oxygen were significantly lower in the older patients than in the younger ones and the controls.
CONCLUSION: Patients with the Fontan circulation have an impaired systolic ventricular function, which correlates with maximal exercise capacity and uptake of oxygen. Those having completion of the Fontan circulation when younger than 18 years had significantly better ventricular function and exercise performance than those who had completion of the Fontan circulation at an older age. An early creation of the Fontan circulation may preserve cardiac function and exercise capacity.

Entities:  

Mesh:

Year:  2009        PMID: 19523267     DOI: 10.1017/S1047951109990424

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  5 in total

1.  Patients with single-ventricle physiology: prognostic implications of stress testing.

Authors:  Brenton S Bauer; Jamil A Aboulhosn; Ryan J Williams; John S Child
Journal:  Pediatr Cardiol       Date:  2011-05-08       Impact factor: 1.655

2.  Impact of sildenafil on echocardiographic indices of myocardial performance after the Fontan operation.

Authors:  David J Goldberg; Benjamin French; Anita L Szwast; Michael G McBride; Bradley S Marino; Nicole Mirarchi; Brian D Hanna; Gil Wernovsky; Stephen M Paridon; Jack Rychik
Journal:  Pediatr Cardiol       Date:  2012-02-14       Impact factor: 1.655

3.  Prognostic power of cardiopulmonary exercise testing in Fontan patients: a systematic review.

Authors:  Sebastian Udholm; Nael Aldweib; Vibeke Elisabeth Hjortdal; Gruschen R Veldtman
Journal:  Open Heart       Date:  2018-07-03

Review 4.  Exercise Intolerance, Benefits, and Prescription for People Living With a Fontan Circulation: The Fontan Fitness Intervention Trial (F-FIT)-Rationale and Design.

Authors:  Derek L Tran; Hannah Gibson; Andrew J Maiorana; Charlotte E Verrall; David W Baker; Melanie Clode; David R Lubans; Diana Zannino; Andrew Bullock; Suzie Ferrie; Julie Briody; Peter Simm; Vishva Wijesekera; Michelle D'Almeida; Sally E Gosbell; Glen M Davis; Robert Weintraub; Anthony C Keech; Rajesh Puranik; Martin Ugander; Robert Justo; Dominica Zentner; Avik Majumdar; Leeanne Grigg; Jeff S Coombes; Yves d'Udekem; Norman R Morris; Julian Ayer; David S Celermajer; Rachael Cordina
Journal:  Front Pediatr       Date:  2022-01-06       Impact factor: 3.418

5.  Circulatory Response to Rapid Volume Expansion and Cardiorespiratory Fitness in Fontan Circulation.

Authors:  Thomas Möller; Vibeke Klungerbo; Simone Diab; Henrik Holmstrøm; Elisabeth Edvardsen; Guro Grindheim; Henrik Brun; Erik Thaulow; Alvaro Köhn-Luque; Assami Rösner; Gaute Døhlen
Journal:  Pediatr Cardiol       Date:  2021-12-17       Impact factor: 1.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.